Ledger.Open graph →
SEC Form D · filed July 2, 2018

Viracta Therapeutics, INC

Offering
$8.5M
Sold
$2.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cardiff, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Britta P. Mccorduck · Charlotte, NCExecTerrence D. Yodaiken · London, United KingdomDirectorKripa Varanasi · WOBURN, MADirectorClare F. Wood · London, United KingdomDirectorMark Little · WOBURN, MADirectorRajesh Unni · WOBURN, MAExec · DirectorFernando C. Verboonen · Rio de Janeiro, GuernseyDirectorWolney C. Betiol · Rio de Janeiro, GuernseyExecKen T. Denman · La Jolla, CAExec · DirectorLegendary Lodging VAB QOZ Manager, LLC · Fargo, NDDirectorAllen Faires · Columbus, OHDirectorAnthony Meyer · New York, NYDirectorPatrick Soon-Shiong · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗